Douglas Merkel to Biomarkers, Tumor
This is a "connection" page, showing publications Douglas Merkel has written about Biomarkers, Tumor.
Connection Strength
0.109
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.097
-
Prognostic factors in breast cancer. Hematol Oncol Clin North Am. 1989 Dec; 3(4):641-52.
Score: 0.012